Microbiome startup MRM Health nabs €55M Series B to run Phase 2b ulcerative colitis trialnews2025-09-04T05:00:41+00:00September 4th, 2025|Endpoints News|
Remedy Meds buys virtual health startup Thirty Madison for $500Mnews2025-09-03T20:35:54+00:00September 3rd, 2025|Endpoints News|
Amgen, Zai Lab say stomach cancer drug’s survival benefit wanednews2025-09-03T20:17:45+00:00September 3rd, 2025|Endpoints News|
Pfizer CEO responds to Trump’s questioning of Covid datanews2025-09-03T17:50:21+00:00September 3rd, 2025|Endpoints News|
Gilead fleshes out $32B US investment plan with a new biologics facilitynews2025-09-03T17:11:11+00:00September 3rd, 2025|Endpoints News|
CDER and CBER offer new submission program for rare disease gene therapiesnews2025-09-03T15:41:24+00:00September 3rd, 2025|Endpoints News|
Mineralys’ strategic stock sale; Gilead, Shoreline partnership endsnews2025-09-03T15:22:35+00:00September 3rd, 2025|Endpoints News|
Novartis signs one of the year’s largest biobuck deals with Shanghai biotech Argonews2025-09-03T14:55:31+00:00September 3rd, 2025|Endpoints News|
AbbVie, AstraZeneca urge judges to toss Louisiana 340B law news2025-09-03T14:25:56+00:00September 3rd, 2025|Endpoints News|
